作为Tenascin-C作为一个目标干预延迟脑性缺血在下大脑关节出血后的干预
Hidenori Suzuki1,2, Fumihiro Kawakita3, Hideki Nakajima3
1Department of Neurosurgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan. suzuki02@med.mie-u.ac.jp.
Acta neurochirurgica. Supplement
|July 9, 2025
概括
在下大脑下出血 (SAH) 后,Tenascin-C (TNC) 的升高有助于延迟大脑缺血症 (DCI). 重用可用的药物来抑制TNC可能会预防或治疗SAH后的DCI.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉瘤下关节出血 (SAH) 与患者的表现不佳有关.
- 延迟大脑缺血症 (DCI) 是影响SAH后结果的主要可治疗因素.
- 增加的田素-C (TNC) 水平与SAH严重程度和DCI发展相关.
研究的目的:
- 为了研究田素-C (TNC) 在延迟脑缺血症 (DCI) 在动脉瘤下arachnoid出血 (SAH) 后的发展中的作用.
- 探索重新利用现有药物的潜力,以针对DCI预防和治疗的TNC.
主要方法:
- 对TNC表达及其与SAH和DCI相关的临床和实验发现的审查.
- 分析TNC作为调节信号通路和炎症分子的母细胞蛋白的功能.
- 检查抑制TNC诱导的现有药物及其在预防DCI方面报告的有效性.
主要成果:
- 更高的SAH严重程度导致大脑组织,血管和脑脊液中TNC增加.
- 通过炎症途径和积极的反机制,TNC促进DCI的发展.
- 通过抑制TNC,西洛斯塔和佩拉曼奈尔在临床上预防DCI方面表现出有希望.
结论:
- 素-C (TNC) 是延迟大脑缺血症 (DCI) 病理生理学中的一个重要因素,发生在动脉瘤下arachnoid出血 (SAH) 后.
- 针对跨国公司为DCI提供了一个有前途的治疗策略.
- 重用临床上可用的抑制TNC诱导的药物为DCI干预提供了一种可行的方法.
相关概念视频
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...